A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-alpha 2b in patients with recurrent epithelial ovarian cancer

E. Dijkgraaf, S. Santegoets, A. Reyners, R. Goedemans, M.C.A. Wouters, G.G. Kenter, A. van Erkel, M.I. van Poelgeest, H. Nijman, J. Hoeven, M. Welters, S. van der Burg, J. Kroep

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2141-2149
JournalAnnals of Oncology
Issue number10
Publication statusPublished - 2015

Cite this